Barely a week later, but only a few buyers are lining up for 23andMe’s parts. The future of the bits and pieces of 23andMe and their 15 million customers apparently are in the Magic 8 Ball’s response ...

The FDA’s Office of Strategic Programs was among the casualties in today’s early-morning layoffs that hit staff across the ...

The genetic testing company has filed for bankruptcy protection and it's unclear what will happen to its massive collection ...

In a March 31, 2025 letter, the Chair of the FTC, Andrew Ferguson, wrote to the Acting U.S. Bankruptcy Trustee and set out the FTC’s expectations ...

As you may know, 23andMe collects and holds sensitive, immutable, identifiable personal information about millions of ...

Since genetics testing firm 23andMe filed for Chapter 11 bankruptcy protection and said it would seek to sell its assets, ...

Agency issues warning about privacy of genetic information and DNA samples. Agency issues warning about privacy of genetic information and DNA samples. Agency issues warning about privacy of genetic ...

As part of the federal process to address its money troubles, the beleaguered biotech firm is looking to sell off its assets.

AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.

The US Federal Trade Commission (FTC) on Monday warned genetic testing firm 23andMe to honor its promise to protect people's ...

OpenSNP, a fourteen-year-old open source repository for genetic records, will shut down and delete all its data at the end of ...

The company filed for bankruptcy after financial challenges over the past few years and a massive data breach in 2023.